HIV/AIDS Blood Safety
Cobas Ampliscreen HIV-1 test detected blood donor seroconversion from minipool
Published in AIDS Weekly, February 13th, 2006
"The introduction of nucleic acid amplification technology (NAT) for screening pooled or individual donations remarkably improved the safety of blood products. The size of minipooled NAT is considered critical for identification of HIV-1 infected donors during preseroconversion phase of infection," scientists in Italy report.
According to the authors, "We describe a case of HIV-1 infection in a serologically negative repeat blood donor identified by 16 minipool (MP) NAT. The donation was tested by Roche Cobas AmpliScreen HIV-1 Test with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-02-13)
More Articles from AIDS Weekly
- HIV/AIDS Diagnostics
Genotypic and phenotypic resistance typing results concordant among HIV/AIDS patients - HIV/AIDS Survival & Mortality
AIDS patient survival is increasing due to HAART and opportunistic infection therapy - Blood Safety
Study questions recent policy on screening of U.S. blood donations for WNV - Business Update
AIDS vaccine, neuroscience drug developer discusses corporate milestones - Diagnostics
Diagnostics company to supply test kits, including VScan, to China hospital in Anhui Province - Drug Development
Viral polypeptide inhibitors target Newcastle disease virus fusion - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
